Skip to Content
Merck
  • A newly established canine NK-type cell line and its cytotoxic properties.

A newly established canine NK-type cell line and its cytotoxic properties.

Veterinary and comparative oncology (2021-03-29)
Malgorzata Grudzien, Aleksandra Pawlak, Justyna Kutkowska, Ewa Ziolo, Edyta Wysokińska, Wojciech Hildebrand, Bożena Obmińska-Mrukowicz, Leon Strzadala, Andrzej Rapak
ABSTRACT

We established a canine natural killer (NK)-type cell line called CNK-89 derived from a dog with NK cell neoplasia. Immunophenotyping analysis showed positive staining for CD5, CD8, CD45, CD56, CD79a and NKp46, while negative for CD3, CD4, CD14, CD20, CD21, CD34, Thy1, IgG, IgM and MHCII. Polymerase chain reaction analysis revealed the presence of CD56, NKG2D, NKp30, NKp44, NKp46 and perforin, but the absence of CD16, Ly49 and granzyme B mRNA. Treating CNK-89 cells with IL-2 did not change the expression of activating receptors, TNFα and IFNγ secretion and cytotoxic activity, however, treatment with IL-12 alone or in combinations with IL-15, IL-18 and IL-21 caused an increase in granzyme B and CD16 mRNA, IFNγ secretion and cytotoxic properties of the CNK-89 cell line.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Dog IgG (whole molecule)–FITC antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution